KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cvs Health (CVS) Capital Expenditures (2016 - 2025)

Cvs Health (CVS) has disclosed Capital Expenditures for 17 consecutive years, with $784.0 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Capital Expenditures rose 2.08% year-over-year to $784.0 million, compared with a TTM value of $2.8 billion through Dec 2025, up 1.83%, and an annual FY2025 reading of $2.8 billion, up 1.83% over the prior year.
  • Capital Expenditures was $784.0 million for Q4 2025 at Cvs Health, up from $698.0 million in the prior quarter.
  • Across five years, Capital Expenditures topped out at $1.1 billion in Q1 2022 and bottomed at $408.0 million in Q2 2022.
  • Average Capital Expenditures over 5 years is $694.6 million, with a median of $679.0 million recorded in 2022.
  • The sharpest move saw Capital Expenditures soared 44.85% in 2023, then fell 28.35% in 2024.
  • Year by year, Capital Expenditures stood at $597.0 million in 2021, then rose by 15.24% to $688.0 million in 2022, then soared by 32.41% to $911.0 million in 2023, then dropped by 15.7% to $768.0 million in 2024, then rose by 2.08% to $784.0 million in 2025.
  • Business Quant data shows Capital Expenditures for CVS at $784.0 million in Q4 2025, $698.0 million in Q3 2025, and $607.0 million in Q2 2025.